Rybelsus is a once-daily tablet that contains semaglutide, the same active ingredient found in Ozempic and Wegovy. Adults with type 2 diabetes take it to improve blood sugar control, and the label also lists a heart-protection use. Rybelsus has strict rules about when and how to swallow it, because the body absorbs very little semaglutide from a tablet. This guide explains what the current U.S. label says about uses, dosing, side effects, interactions, and safety.
The facts below come mainly from the current Rybelsus and Ozempic tablets prescribing information published by Novo Nordisk (revised January 2026). Labels change over time, so check the newest version and the Medication Guide that comes with your prescription.
What Is Rybelsus?
Rybelsus is a brand-name prescription medicine from Novo Nordisk. Semaglutide belongs to a group of medicines called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. Semaglutide copies that hormone but lasts much longer, with a half-life of about one week. The FDA approved Rybelsus in 2019 as the first GLP-1 medicine you swallow rather than inject.
The tablet contains an ingredient called salcaprozate sodium (SNAC) that helps semaglutide absorb in the stomach. Even so, the label estimates that only about 0.4% to 1% of a Rybelsus dose reaches the bloodstream, which explains the detailed instructions below.
Rybelsus and Ozempic Tablets
The current label now covers two tablet brands in one document: Rybelsus (3 mg, 7 mg, and 14 mg) and Ozempic tablets (1.5 mg, 4 mg, and 9 mg). The label states they are not interchangeable milligram for milligram. A 7 mg Rybelsus tablet matches the 4 mg Ozempic tablet, and 14 mg matches 9 mg. Never swap brands or strengths on your own. Ozempic tablets are different from Ozempic injections, which have their own label.
What Is Rybelsus Used For?
According to the current label, Rybelsus is approved for adults with type 2 diabetes in two ways:
- Blood sugar control. Doctors use it with diet and exercise to improve glycemic control.
- Heart protection. It lowers the risk of major cardiovascular events (cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events.
Rybelsus is not a weight-loss product, although weight often falls. In the monotherapy trial, average weight change at 26 weeks was about 3.7 kg (roughly 8 lb) lower on 14 mg and 2.3 kg lower on 7 mg, compared with 1.4 kg lower on placebo. Wegovy tablets are the semaglutide tablets approved for weight management, and they follow a separate label. The Rybelsus label states that safety and effectiveness in children have not been established.
How Well Does It Lower Blood Sugar?
HbA1c is a blood test that reflects your average blood sugar over about three months. In a 26-week trial of adults on diet and exercise alone, HbA1c fell by 1.2 percentage points on 7 mg and 1.4 on 14 mg, compared with 0.3 on placebo. In adults already taking metformin, Rybelsus 14 mg lowered HbA1c by 1.3, compared with 0.9 for empagliflozin 25 mg. Against sitagliptin 100 mg (a DPP-4 inhibitor pill), the drops were 1.0 for 7 mg and 1.3 for 14 mg, versus 0.8. Against liraglutide 1.8 mg (a daily GLP-1 injection), Rybelsus 14 mg was non-inferior, meaning it worked about as well: 1.2 versus 1.1.
Heart Outcomes
In a trial of 9,650 adults with type 2 diabetes and heart or kidney disease, major cardiovascular events happened in 12.0% of people taking Rybelsus 14 mg and 13.8% of people on placebo over a median of about four years (hazard ratio 0.86). The drop came mainly from fewer non-fatal heart attacks. Results describe groups, not individuals.
How Does Rybelsus Work?
Semaglutide lowers blood sugar in a way that depends on your glucose level. When blood sugar is high, it prompts the pancreas to release more insulin and lowers glucagon, a hormone that raises blood sugar. When blood sugar is normal, this effect fades. The medicine also slows early stomach emptying slightly, which reduces the blood sugar spike after meals and explains some digestive side effects.
How to Take Rybelsus Safely
Dosing Basics
Your prescriber sets your dose. For general understanding, the label describes this pattern:
- Days 1 to 30: 3 mg once daily. The label states this starter dose is not effective for blood sugar control. It only helps your body adjust.
- Days 31 to 60: 7 mg once daily.
- Day 61 and later: Stay on 7 mg if no more control is needed, or move to 14 mg if more is needed.
Do not use this list to set your own dose. Do not switch between Rybelsus and Ozempic tablets during the first 30 days. If you switch from Ozempic injections (the 0.5 mg dose), the label says to start a tablet one week after your last injection.
The Rules for Taking the Tablet
- Take one tablet in the morning on an empty stomach.
- Swallow it with plain water, no more than 4 ounces. Do not use coffee, juice, or other liquids.
- Swallow it whole. Do not split, crush, chew, or dissolve it.
- Wait at least 30 minutes before you eat, drink, or take other oral medicines.
- Do not take more than one tablet per day.
These rules matter. In label studies, absorption was higher with a small amount of water than with a large amount, and it was higher after a longer wait before eating. Taking the tablet with food or extra liquid can lower the amount your body absorbs.
What to Do If You Miss a Dose
Skip the missed dose and take your next tablet the following day, on your regular schedule. Do not take two tablets in one day.
Common Side Effects of Rybelsus
Digestive problems are the most common. In placebo-controlled trials in adults with type 2 diabetes, these effects each affected at least 5% of people taking Rybelsus:
| Side effect | Placebo | Rybelsus 7 mg | Rybelsus 14 mg |
|---|---|---|---|
| Nausea | 6% | 11% | 20% |
| Abdominal pain | 4% | 10% | 11% |
| Diarrhea | 4% | 9% | 10% |
| Decreased appetite | 1% | 6% | 9% |
| Vomiting | 3% | 6% | 8% |
| Constipation | 2% | 6% | 5% |
Overall, 41% of people on 14 mg and 32% of people on 7 mg had a digestive reaction, versus 21% on placebo. The label says most nausea, vomiting, and diarrhea happened during dose increases. About 8% of people on 14 mg and 4% on 7 mg stopped Rybelsus because of digestive effects, compared with 1% on placebo. Resting heart rate rose by an average of 1 to 3 beats per minute. After approval, people also reported hair loss, dizziness, headache, and an altered sense of taste.
Serious Side Effects and Warnings
Boxed Warning: Thyroid C-Cell Tumors
Rybelsus carries the FDA’s strongest warning. In rodents, semaglutide caused thyroid C-cell tumors. No one knows whether it causes these tumors, including a rare cancer called medullary thyroid carcinoma (MTC), in people. Do not use Rybelsus if you or a family member has had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Report a neck lump, trouble swallowing, shortness of breath, or lasting hoarseness.
Other Important Warnings
- Pancreatitis. Severe, persistent stomach pain, sometimes spreading to the back, calls for stopping the medicine and getting help right away.
- Diabetic eye disease. Rapid blood sugar improvement can temporarily worsen retinopathy. Report vision changes.
- Low blood sugar. The risk rises when you combine Rybelsus with insulin or a sulfonylurea (a type of diabetes pill). Your prescriber may lower those doses.
- Kidney injury. Vomiting and diarrhea can dehydrate you and injure the kidneys. Some people needed dialysis.
- Severe stomach problems. Severe digestive reactions affected 2% of people on 14 mg and 0.3% on placebo. The label does not recommend Rybelsus in people with severe gastroparesis (very slow stomach emptying). Reports after approval include bowel blockage and severe constipation.
- Serious allergic reactions. Swelling of the face, lips, tongue, or throat, trouble breathing, or severe rash needs emergency care.
- Gallbladder disease. In the heart trial, gallstones affected 1.1% of Rybelsus users versus 0.9% on placebo, and gallbladder inflammation affected 1.1% versus 0.7%.
- Anesthesia and sedation. Slower stomach emptying can leave food in the stomach even after fasting, and stomach contents can reach the lungs during anesthesia or deep sedation. Tell every surgeon, dentist, and anesthesia provider that you take Rybelsus.
Who Should Avoid Rybelsus or Use Caution?
The label lists two contraindications: a personal or family history of MTC or MEN 2, and a prior serious allergic reaction to semaglutide or any ingredient. Tell your prescriber before you start if you have had pancreas or kidney problems, diabetic eye disease, severe stomach problems, or a planned procedure that uses anesthesia.
The label found no overall differences in safety or effectiveness in adults 65 and older. It recommends the same dose for people with kidney or liver impairment, and one trial included 324 people with moderate kidney impairment.
Rybelsus Drug Interactions
Because Rybelsus slows stomach emptying, it can change how other pills are absorbed. The best-documented example is levothyroxine, a thyroid hormone medicine: its exposure rose by 33% when taken with semaglutide tablets. The label advises extra monitoring for oral medicines that have a narrow safety margin or need regular lab checks. Studies found no clinically significant effects on omeprazole, lisinopril, warfarin, metformin, digoxin, birth control hormones (ethinyl estradiol and levonorgestrel), furosemide, or rosuvastatin.
Timing matters too. Since you must wait 30 minutes after Rybelsus before taking other oral medicines, plan your morning routine so your other pills are not delayed longer than your prescriber advises. Insulin and sulfonylureas raise the risk of low blood sugar. Give your pharmacist a full list of your prescriptions, over-the-counter medicines, vitamins, and supplements.
Pregnancy and Breastfeeding
Pregnancy. Human data are insufficient. Animal studies showed possible harm to the fetus, and the label says to use Rybelsus in pregnancy only if the potential benefit justifies the risk. It advises stopping at least 2 months before a planned pregnancy because semaglutide leaves the body slowly, and the label says semaglutide stays in the bloodstream for about five weeks after the last dose. Poorly controlled diabetes also carries real risks during pregnancy, so talk with your doctor about a safe plan for blood sugar before you conceive.
Breastfeeding. The label says breastfeeding is not recommended during treatment. Semaglutide was not detectable in breast milk in a study, but SNAC or its by-products pass into milk, and infants may clear SNAC more slowly than adults.
How to Store Rybelsus
- Store at 68°F to 77°F (20°C to 25°C). Brief excursions to 59°F to 86°F are allowed.
- Keep tablets in the original bottle until you are ready to take one, and do not move them to a pill organizer or another container for long-term storage.
- Protect tablets from moisture. Store the bottle in a dry place.
- Keep the bottle out of the reach of children.
Counterfeit and Unapproved Semaglutide
High demand for semaglutide products has created a market for unapproved copies. The FDA states that compounded GLP-1 drugs are not FDA approved, and it has received reports of dosing errors, side effects, and fraudulent products. Use only prescriptions from licensed pharmacies, and report suspicious products to your pharmacist and to the FDA’s MedWatch program.
When to Get Medical Help
Call 911 or go to an emergency room for trouble breathing or swelling of the face, lips, tongue, or throat. Contact a healthcare provider promptly for severe or lasting stomach pain, repeated vomiting or diarrhea, signs of dehydration, a neck lump, vision changes, upper belly pain with fever or yellowing skin, or symptoms of low blood sugar such as shakiness, sweating, confusion, or a fast heartbeat. In case of an overdose, call Poison Help at 1-800-222-1222.
Frequently Asked Questions About Rybelsus
Is Rybelsus approved for weight loss?
No. Rybelsus is approved for type 2 diabetes and for heart-risk reduction in high-risk adults with type 2 diabetes. Weight often drops during treatment, but the semaglutide tablet approved for weight management is Wegovy.
Can I take Rybelsus with my morning coffee?
No. The label says to take it with plain water only, up to 4 ounces, on an empty stomach, and to wait at least 30 minutes before you eat, drink, or take other pills.
Why does the first month use a dose that does not lower blood sugar?
The 3 mg dose is a starter dose. The label says it is not effective for blood sugar control and exists to reduce stomach side effects as your body adjusts.
Is Rybelsus the same as Ozempic?
Both contain semaglutide, but they are separate products. Ozempic is also sold as an injection, and Ozempic tablets share a label with Rybelsus. Strengths are not interchangeable, so follow the exact product your prescriber chose.
Can I take Rybelsus with other diabetes medicines?
Doctors often combine it with metformin and other diabetes medicines. The risk of low blood sugar rises with insulin and sulfonylureas, so your prescriber may adjust those doses.
What happens if I stop taking Rybelsus?
Talk with your prescriber first, because your blood sugar plan may need to change. Semaglutide stays in the body for roughly five weeks after the last dose, according to the label.
References
- Rybelsus and Ozempic (semaglutide) tablets prescribing information and Medication Guide, Novo Nordisk (revised 1/2026)
- GLP-1 agonists, MedlinePlus Medical Encyclopedia
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Conclusion
Rybelsus is a once-daily semaglutide tablet for adults with type 2 diabetes, with an added approval for lowering heart risk in high-risk patients. It can lower blood sugar about as well as several other diabetes medicines, but it works only if you follow the empty-stomach, small-sip-of-water, wait-30-minutes routine. It also carries a boxed warning and real risks, including digestive problems, pancreatitis, dehydration, and gallbladder disease. Follow your prescriber’s plan, tell every care provider before a procedure, and buy only genuine product from a licensed pharmacy.
Medical Disclaimer
Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided is not a substitute for professional medical advice from a qualified healthcare provider. Always consult your doctor or pharmacist before starting, stopping, or changing any medication. Do not disregard professional medical advice or delay seeking it because of information in this article. If you think you are experiencing a medical emergency, seek emergency medical assistance immediately.